Back to Neurology
NeurologyvModifiedEvidence-Based

Modified Hoehn and Yahr Scale for Parkinson's Disease

Grades severity of symptoms in Parkinson's disease with intermediate stages for better disease progression tracking

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
hoehn yahr stage
—stage
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Modified Hoehn and Yahr Scale for Parkinson's Disease is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Clinical staging based on motor symptoms: Stage 1 (unilateral), 1.5 (unilateral + axial), 2 (bilateral, balance intact), 2.5 (bilateral, recovers on pull-test), 3 (bilateral, postural instability), 4 (severe disability, independent), 5 (wheelchair/bed-bound).

Clinical Pearls & Practice Notes

  • Modified version adds intermediate stages 1.5 and 2.5 to original 1967 scale
  • Higher stages correlate with greater disability and reduced quality of life
  • Stages 1-3 considered minimally disabling, stages 4-5 severely disabling
  • Movement Disorder Society recommends using original 1-5 scale due to lack of validation of 0.5 increments
  • Primary focus on motor symptoms; does not assess non-motor features
  • Useful for tracking disease progression and clinical decision-making
  • Can guide decisions about medication adjustments, surgical interventions, and care planning
  • Does not capture cognitive decline, mood disorders, or other non-motor symptoms
  • Should be used alongside other assessment tools for comprehensive evaluation
  • Pull test: examiner stands behind patient and pulls backward on shoulders

Evidence & Literature Citations

  1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427-42. doi: 10.1212/wnl.17.5.427.
  2. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov Disord. 2004 Sep;19(9):1020-8. doi: 10.1002/mds.20213.
  3. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol. 2010 Jan;67(1):64-70. doi: 10.1001/archneurol.2009.295.

Score Interpretation Ranges

Stage 11 – 1 pts

Unilateral involvement only

Stage 1.51.5 – 1.5 pts

Unilateral and axial involvement

Stage 22 – 2 pts

Bilateral involvement without impairment of balance

Stage 2.52.5 – 2.5 pts

Mild bilateral disease with recovery on pull test

Stage 33 – 3 pts

Bilateral disease; mild to moderate disability

Stage 44 – 4 pts

Severe disability; still able to walk or stand unassisted

Stage 55 – 5 pts

Confinement to bed or wheelchair unless aided

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.